Prof.Dr.Stehling Institut für Bildgebende DIAGNOSTIK
Strahlenberger Straße 110
63067 Offenbach - Kaiserlei
Phone: +49 69-50 50 00 90
Fax: +49 69-50 50 00 98-8
E-Mail: info@bilddiagnostik.de
Internet: www.bilddiagnostik.de
Opening Hours
Monday-Friday: 8:00 am – 8:00 pm
Saturday: 10:00 am – 2:00 pm
Sunday and Bank Holidays:
By appointment

Over the past 18 months we have successfully treated well over 400 patients, without complications.
| General Improvements | Improvement oft the motoric system / sensory system |
Treatment response in fatigue |
complications |
|
| strong | 60/100 | 40/100 | 35/100 | 0/100 |
| moderate |
33/100 | 50/100 | 39/100 | 2*/100 |
| Not any | 7/100 | 10/100 | 26/100 | 98/100 |
*accidental arterial puncture /small extraversation
CCSVI is an unproven theory and criticised by some Neurologist world-wide. “It is very dangerous and all placebo” some Neurologists say.
We and other Neurologists do not agree: As for safety, we have not seen and dangerous complications.
But: any kind of medical treatment will cause side effects to some extent, even pharmacotherapy of MS.
And for placebo: Well, we do not know for sure until the results from well designed randomised trials are available. But placebo effects usually do not occur in almost all treated patients. And they do not last for as long as a whole year.
In synopsis of the overall safety record of CCSVI treatment and experience of our patients, particularly in view of the impressive improvements treated patients have experienced, we consider it unethical to withhold this treatment from those patients who are aware of and willing to accept its experimental nature.
Read more about the CCSVI improved diagnostic protocol…
Read more about the CCSVI Liberation Treatment…
Read more about Treatment with bone marrow adult autologous Stem Cells and special Physiotherapy...
Read more about the CCSVI Treatment with CCSVI Venous Stents…
Toll-Free Telephone-Consultation
+49 69-50 50 00 90
Callback
If you prefer to get a call-back, just fill in and send this form, please